University Heidelberg
Welcome,         Profile    Billing    Logout  
 3 Trials 
8 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Kreuter, Michael
IMPALA-2, NCT04544293 / 2020-001263-85: Clinical Trial of Inhaled Molgramostim Nebulizer Solution in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)

Active, not recruiting
3
160
Europe, Canada, Japan, US, RoW
Molgramostim, Recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF), Placebo
Savara Inc., Savara ApS,
Autoimmune Pulmonary Alveolar Proteinosis
11/23
11/24
BEconneCTD-ILD, NCT06572384: A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

Recruiting
3
440
Europe, Japan, US, RoW
Belimumab, BENLYSTA, GSK1550188, Placebo
GlaxoSmithKline
Lung Diseases, Interstitial
10/28
12/28
NCT05130970 / 2021-003162-12: Garadacimab Safety, Pharmacokinetics, and Pharmacodynamics in Idiopathic Pulmonary Fibrosis

Completed
2
81
Europe, Canada, US, RoW
Garadacimab, Factor XIIa antagonist monoclonal antibody, CSL312, Placebo
CSL Behring
Idiopathic Pulmonary Fibrosis
01/24
01/24
I-FILE, NCT04304898: An International Patient-led Registry in Fibrotic Interstitial Lung Diseases Using eHealth Technology

Recruiting
N/A
700
Europe
Home spirometry
Erasmus Medical Center
Pulmonary Fibrosis
07/25
07/26
ILDnose, NCT04680832: Exhaled Breath Analysis Using eNose Technology as a Biomarker for Diagnosis and Disease Progression in Fibrotic ILD

Recruiting
N/A
600
Europe
Electronic nose, SpiroNose, eNose
Erasmus Medical Center
Pulmonary Fibrosis
12/25
12/26
Jacobi, Heike
HSP-PBP, NCT03981276: Phenotypes, Biomarkers and Pathophysiology in Hereditary Spastic Paraplegias and Related Disorders

Recruiting
N/A
2000
Europe
Clinical rating scale to measure disease severity and progression, Spastic Paraplegia Rating Scale (SPRS), Next-Gen Sequencing (NGS)
Dr. Rebecca Schule, German Federal Ministry of Education and Research, German Center for Neurodegenerative Diseases (DZNE)
Hereditary Spastic Paraplegia
08/39
08/41
Leitzmann, Michael
NCT06496711: IMPLEMENT - Model Project for Quality-assured Exercise Therapy for Cancer Patients

Recruiting
N/A
600
Europe
Cancer Patients; Institutions and their employees in the treatment and/or counseling of cancer patients
University of Cologne, Leibniz Institute for Prevention Research and Epidemiology - BIPS GmbH, University of Regensburg, Ludwig-Maximilians - University of Munich, Technical University of Munich, Martin-Luther-Universität Halle-Wittenberg, University Hospital Schleswig-Holstein, Universitätsklinikum Hamburg-Eppendorf, University Hospital, Essen
Cancer
11/25
02/26
COPLANT, NCT06323538: Cohort Study on Plant-based Diets ( Study)

Not yet recruiting
N/A
6000
Europe
German Federal Institute for Risk Assessment, Max Rubner-Institut, University of Bonn, Research Institute for Plant-Based Nutrition, University of Jena, University of Regensburg, Heidelberg University, University of Vienna
Dietary Exposure, Diabetes Mellitus, Type 2, Cardiovascular Diseases, Bone Loss, Sustainability, Exposure, Obesity, Vitamin Deficiency, Mineral Deficiency
03/27
03/47

Download Options